These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15261229)

  • 61. Hypothyroidism unmasking proximal myotonic myopathy.
    Sansone V; Griggs RC; Moxley RT
    Neuromuscul Disord; 2000 Mar; 10(3):165-72. PubMed ID: 10734262
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families.
    Saito T; Amakusa Y; Kimura T; Yahara O; Aizawa H; Ikeda Y; Day JW; Ranum LP; Ohno K; Matsuura T
    Neurogenetics; 2008 Feb; 9(1):61-3. PubMed ID: 18057971
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Musculoskeletal pain as the most prominent feature in myotonic dystrophy type 2].
    George A; Schneider-Gold C; Reiners K; Sommer C
    Schmerz; 2006 Sep; 20(5):388, 390-4, 396-7. PubMed ID: 16758212
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A patient with proximal myotonic myopathy and parkinsonism.
    Chu K; Cho JW; Song EC; Jeon BS
    Can J Neurol Sci; 2002 May; 29(2):188-90. PubMed ID: 12035844
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.
    Ricker K; Koch MC; Lehmann-Horn F; Pongratz D; Speich N; Reiners K; Schneider C; Moxley RT
    Arch Neurol; 1995 Jan; 52(1):25-31. PubMed ID: 7826272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of repetitive regions in myotonic dystrophy type 1 and 2.
    Carson NL
    Curr Protoc Hum Genet; 2009 Apr; Chapter 9():Unit 9.6. PubMed ID: 19360700
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Molecular and genetic aspects of the myotonic conditions].
    Morales Montero F; Cuenca Berger P
    Rev Neurol; 2004 Apr 1-15; 38(7):668-74. PubMed ID: 15098190
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Report of the 84th ENMC workshop: PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. 13-15th October, 2000, Loosdrecht, The Netherlands.
    Moxley RT; Meola G; Udd B; Ricker K
    Neuromuscul Disord; 2002 Mar; 12(3):306-17. PubMed ID: 11801405
    [No Abstract]   [Full Text] [Related]  

  • 70. [Four family members with proximal myotonic myopathy].
    Tieleman AA; van der Velden MP; Visser MC; Wokke JH; Scheffer H; van Engelen BG
    Ned Tijdschr Geneeskd; 2004 May; 148(19):948-52. PubMed ID: 15160562
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
    Margolis JM; Schoser BG; Moseley ML; Day JW; Ranum LP
    Hum Mol Genet; 2006 Jun; 15(11):1808-15. PubMed ID: 16624843
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype.
    Bugiardini E; Rivolta I; Binda A; Soriano Caminero A; Cirillo F; Cinti A; Giovannoni R; Botta A; Cardani R; Wicklund MP; Meola G
    Neuromuscul Disord; 2015 Apr; 25(4):301-7. PubMed ID: 25660391
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy.
    Chen W; Wang Y; Abe Y; Cheney L; Udd B; Li YP
    J Mol Biol; 2007 Apr; 368(1):8-17. PubMed ID: 17335846
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Myotonic dystrophy type 2 is rare in the Japanese population.
    Matsuura T; Minami N; Arahata H; Ohno K; Abe K; Hayashi YK; Nishino I
    J Hum Genet; 2012 Mar; 57(3):219-20. PubMed ID: 22258159
    [No Abstract]   [Full Text] [Related]  

  • 75. Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.
    Schneider-Gold C; Beck M; Wessig C; George A; Kele H; Reiners K; Toyka KV
    Neurology; 2003 Feb; 60(3):500-2. PubMed ID: 12578937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proximal myotonic myopathy and proximal myotonic dystrophy: two different entities? The phenotypic variability of proximal myotonic syndromes.
    Schneider C; Wessig C; Müller CR; Brechtelsbauer D; Grimm T
    Neuromuscul Disord; 2001 Jul; 11(5):485-8. PubMed ID: 11404122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.
    Meola G; Sansone V; Perani D; Colleluori A; Cappa S; Cotelli M; Fazio F; Thornton CA; Moxley RT
    Neurology; 1999 Sep; 53(5):1042-50. PubMed ID: 10496264
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature.
    Meola G; Sansone V
    Ital J Neurol Sci; 1996 Oct; 17(5):347-53. PubMed ID: 8933228
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The short exercise test is normal in proximal myotonic myopathy.
    Sander HW; Scelsa SN; Conigliari MF; Chokroverty S
    Clin Neurophysiol; 2000 Feb; 111(2):362-6. PubMed ID: 10680573
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A 14-Year Italian Experience in DM2 Genetic Testing: Frequency and Distribution of Normal and Premutated
    Botta A; Visconti VV; Fontana L; Bisceglia P; Bengala M; Massa R; Bagni I; Cardani R; Sangiuolo F; Meola G; Antonini G; Petrucci A; Pegoraro E; D'Apice MR; Novelli G
    Front Genet; 2021; 12():668094. PubMed ID: 34234810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.